Literature DB >> 18084722

Role of ACE/AT2R complex in the control of mesenteric resistance artery contraction induced by ACE/AT1R complex activation in response to Ang I.

Jun Su1, Desiree I Palen, Hamid Boulares, Khalid Matrougui.   

Abstract

OBJECTIVES: In this study, we will determine the function of the interaction between AT2R and ACE, and AT1R and ACE in the control of mesenteric resistance artery (MRA) tone from normotensive (NT) and Angiotensin II (AII)-dependent hypertensive (HT) mice. METHODS-
RESULTS: Hypertension was induced by infusion of Ang-II (200 ng/kg/day) for 3 weeks. Freshly MRA (100-120 microm) were isolated from HT and NT mice and mounted in an arteriograph. Dose-response of Ang-I induced a similar contraction of MRA from NT and HT mice, which was increased after endothelium removal. AT2R antagonist (PD123319, 1 microM) significantly increased Ang-I-induced contraction of MRA from NT but not from HT mice. In addition, PD123319 significantly increased in vivo blood pressure in response to Ang-I. Luminal incubation with ACE-antibody (50 ng/ml) to block only endothelial ACE function significantly enhanced Ang-I-induced contraction of MRA from NT mice. ACE inhibitor (captopril, 10 microM) completely blocked Ang-I-induced contraction of MRA from both animals and prevented the increased blood pressure. Freshly isolated MRA subjected to immunoprecipitation, Western blot analysis and RT-PCR revealed AT1R/ACE and AT2R/ACE complexes formation, and similar AT1R, AT2R, and ACE expression level in both groups.
CONCLUSION: The present findings show the existence of ACE/AT2R and ACE/AT1R complexes on endothelial cells and VSMC, respectively. ACE/AT2R complex plays a modulator effect on ACE/AT1R-SMC-induced contraction of MRA, which is altered in hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18084722      PMCID: PMC2715550          DOI: 10.1007/s11010-007-9686-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  Resistance artery tone is influenced independently by pressure and by flow.

Authors:  J A Bevan; J L Garcia-Roldan; E H Joyce
Journal:  Blood Vessels       Date:  1990

Review 2.  Vascular myogenic or stretch-dependent tone.

Authors:  J A Bevan
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

3.  High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats.

Authors:  Dong You; Laurent Loufrani; Celine Baron; Bernard I Levy; Robert E Widdop; Daniel Henrion
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

4.  High NaCl intake decreases both flow-induced dilation and pressure-induced myogenic tone in resistance arteries from normotensive rats: involvement of cyclooxygenase-2.

Authors:  K Matrougui; L Loufrani; B I Lévy; D Henrion
Journal:  Pharmacol Toxicol       Date:  2001-10

Review 5.  Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control.

Authors:  V J Dzau
Journal:  J Hypertens Suppl       Date:  1988-12

Review 6.  The clinical use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.

Authors:  J I Robertson; D M Tillman; G W Herd
Journal:  Clin Exp Hypertens A       Date:  1987

7.  Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.

Authors:  Yasuhiro Izumiya; Shokei Kim; Yasukatsu Izumi; Kaoru Yoshida; Minoru Yoshiyama; Atsushi Matsuzawa; Hidenori Ichijo; Hiroshi Iwao
Journal:  Circ Res       Date:  2003-10-09       Impact factor: 17.367

Review 8.  Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.

Authors:  B Waeber; L Juillerat-Jeanneret; J F Aubert; M Schapira; J Nussberger; H R Brunner
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

9.  Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.

Authors:  Ming Li; Ke Liu; Jan Michalicek; James A Angus; John E Hunt; Louis J Dell'Italia; Michael P Feneley; Robert M Graham; Ahsan Husain
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 10.  Converting enzyme inhibitors in the treatment of hypertension.

Authors:  J I Robertson; D M Tillman
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

View more
  4 in total

1.  Characterization of the thoracodorsal artery: morphology and reactivity.

Authors:  Marie Billaud; Alexander W Lohman; Adam C Straub; Thibaud Parpaite; Scott R Johnstone; Brant E Isakson
Journal:  Microcirculation       Date:  2012-05       Impact factor: 2.628

2.  Ontogeny of angiotensin type 2 and type 1 receptor expression in mice.

Authors:  Juan Gao; Jie Chao; Karma-Jaya K Parbhu; Li Yu; Liang Xiao; Fei Gao; Lie Gao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-04-22       Impact factor: 1.636

3.  Role of copper transport protein antioxidant 1 in angiotensin II-induced hypertension: a key regulator of extracellular superoxide dismutase.

Authors:  Kiyoshi Ozumi; Varadarajan Sudhahar; Ha Won Kim; Gin-Fu Chen; Takashi Kohno; Lydia Finney; Stefan Vogt; Ronald D McKinney; Masuko Ushio-Fukai; Tohru Fukai
Journal:  Hypertension       Date:  2012-07-02       Impact factor: 10.190

4.  Translational value of mechanical and vasomotor properties of mouse isolated mesenteric resistance-sized arteries.

Authors:  Emilie M Outzen; Marina Zaki; Bahareh Abdolalizadeh; Anette Sams; Harrie C M Boonen; Majid Sheykhzade
Journal:  Pharmacol Res Perspect       Date:  2015-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.